These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 16234132)

  • 41. Is ecstasy a drug of dependence?
    Degenhardt L; Bruno R; Topp L
    Drug Alcohol Depend; 2010 Feb; 107(1):1-10. PubMed ID: 19836170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
    Gouzoulis-Mayfrank E; Daumann J
    J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of ecstasy on the body].
    Saarijärvi S; Lopperi M
    Duodecim; 2003; 119(13):1211-5. PubMed ID: 12908183
    [No Abstract]   [Full Text] [Related]  

  • 44. 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment.
    Logan BK; Couper FJ
    J Forensic Sci; 2001 Nov; 46(6):1426-33. PubMed ID: 11714155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion.
    Gurtman CG; Morley KC; Li KM; Hunt GE; McGregor IS
    Eur J Pharmacol; 2002 Jun; 446(1-3):89-96. PubMed ID: 12098589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Psychiatric and cognitive long-term effects of ecstasy].
    Høiseth G; Løvåsdal Ø; Titze TK; Bramness JG; Bachs L
    Tidsskr Nor Laegeforen; 2006 Feb; 126(5):596-8. PubMed ID: 16505868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients.
    Schifano F; Di Furia L; Forza G; Minicuci N; Bricolo R
    Drug Alcohol Depend; 1998 Sep; 52(1):85-90. PubMed ID: 9788011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls.
    Lamers CT; Bechara A; Rizzo M; Ramaekers JG
    J Psychopharmacol; 2006 Mar; 20(2):302-11. PubMed ID: 16510488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Behavioral and neurochemical consequences of multiple MDMA administrations in the rat: role of individual differences in anxiety-related behavior.
    Ludwig V; Mihov Y; Schwarting RK
    Behav Brain Res; 2008 May; 189(1):52-64. PubMed ID: 18241937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and characterization of a novel animal model of intermittent MDMA ("Ecstasy") exposure during adolescence.
    Meyer JS; Piper BJ; Vancollie VE
    Ann N Y Acad Sci; 2008 Oct; 1139():151-63. PubMed ID: 18991859
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo.
    Johanson CE; Kilbey M; Gatchalian K; Tancer M
    Drug Alcohol Depend; 2006 Jan; 81(1):27-36. PubMed ID: 15975736
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Update on gamma-hydroxybutyric acid].
    García FB; Pedraza C; Navarro JF
    Rev Neurol; 2006 Jul 1-15; 43(1):39-48. PubMed ID: 16807871
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry.
    van Nieuwenhuijzen PS; McGregor IS
    Drug Alcohol Depend; 2009 Aug; 103(3):137-47. PubMed ID: 19446408
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new brain area affected by 3,4-methylenedioxymethamphetamine: A microdialysis-biotelemetry study.
    Benamar K; Geller EB; Adler MW
    Eur J Pharmacol; 2008 Oct; 596(1-3):84-8. PubMed ID: 18727928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').
    McCann UD; Slate SO; Ricaurte GA
    Drug Saf; 1996 Aug; 15(2):107-15. PubMed ID: 8884162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of 3,4-methylenedioxymethamphetamine on the toxicokinetics and sedative effects of the drug of abuse, γ-hydroxybutyric acid.
    Vijay N; Morris ME
    J Pharm Sci; 2014 Oct; 103(10):3310-5. PubMed ID: 25174723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ecstasy related periodontitis and mucosal ulceration -- a case report.
    Brazier WJ; Dhariwal DK; Patton DW; Bishop K
    Br Dent J; 2003 Feb; 194(4):197-9. PubMed ID: 12627194
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The many faces of ecstasy.
    Doyon S
    Curr Opin Pediatr; 2001 Apr; 13(2):170-6. PubMed ID: 11317061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The reality of psychomotor problems, and the possibility of Parkinson's disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003).
    Parrott AC; Rodgers J; Buchanan T; Scholey AB; Heffernan T; Ling J
    Psychopharmacology (Berl); 2004 Jan; 171(2):231-3. PubMed ID: 14634710
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.